Opko Health shares are trading higher after Barrington Research upgraded the stock from Market Perform to Outperform and announced a $2 price target.
Portfolio Pulse from Benzinga Newsdesk
Opko Health's stock has been upgraded from Market Perform to Outperform by Barrington Research, which also set a price target of $2. This has led to an increase in the trading of Opko Health shares.
June 29, 2023 | 5:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Opko Health's stock has been upgraded by Barrington Research, leading to increased trading. The new price target is $2.
The upgrade from Barrington Research is a positive signal for investors, which has led to increased trading of Opko Health's shares. The new price target of $2 also provides a clear expectation for the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100